Moderna Stock Drops Over 9% Despite Little News; Co-Founder Sells $1.65 Million in Shares
-
Moderna stock dropped 9.1% on Monday despite little fundamental news on the company.
-
Co-founder and board member Noubar Afeyan sold 15,000 shares worth $1.65 million.
-
The sale was scheduled under SEC Rule 10b5-1, allowing executives to plan sales to reduce positions.
-
Pfizer and BioNTech shares also declined, suggesting weakness in vaccine stocks overall.
-
Moderna gained 8.3% last week, so today's drop may just be typical volatility for the stock.